Skip to main content

Advertisement

Table 1 Baseline characteristics of dogs assigned to each study group, and homogeneity analysis data, expressed as mean ± standard deviation and frequencies (%)

From: Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound

Variable Supplement group Placebo group P-value supplement vs placeboa
Gender: female, n (%) 10 (50) 7 (31.8) 0.346
Age: months 63.75 ± 33.78 67.36 ± 31.05 0.720
Age groups: n (%)    1.000
  < 3 years 3 (15) 3 (13.6)  
 3 to 8 years 13 (65) 15 (68.2)  
  > 8 years 4 (20) 4 (18.2)  
Clinical score: points 0.80 ± 1.28 0.95 ± 1.73 0.756
ELISA serology: arbitrary units 3.31 ± 1.53 2.38 ± 1.46 0.054
RT-PCR: parasites/ng of DNA 0.22 ± 0.54 0.66 ± 1.89 0.420
Body temperature: °C 38.33 ± 0.49 38.40 ± 0.41 0.590
Weight: kg 27.90 ± 12.10 25.78 ± 15.11 0.621
  1. aP-values were calculated with Student’s t-test for quantitative variables and Fisher’s exact test for categorical variables